27.12.2012 Views

A Textbook of Clinical Pharmacology and Therapeutics

A Textbook of Clinical Pharmacology and Therapeutics

A Textbook of Clinical Pharmacology and Therapeutics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

222 CARDIAC DYSRHYTHMIAS<br />

Synchronised DC shock*<br />

up to 3 attempts<br />

• Amiodarone 300 mg IV over 10–20<br />

min <strong>and</strong> repeat shock; followed by;<br />

• Amiodarone 900 mg over 24 h<br />

Irregular<br />

Seek expert help<br />

Possibilities include:<br />

• AF with bundle branch block<br />

treat as for narrow complex<br />

• Pre-excited AF<br />

consider amiodarone<br />

• Polymorphic VT (e.g.<br />

torsades de pointes – give<br />

magnesium 2 g over 10 min)<br />

Unstable<br />

Is QRS regular?<br />

*Attempted electrical cardioversion is<br />

always undertaken under sedation<br />

or general anaesthesia<br />

provides a simple <strong>and</strong> practical algorithm for the management<br />

<strong>of</strong> tachydysrhythmias in general.<br />

Catheter ablation therapy is now possible for supraventricular<br />

tachycardias, atrial flutter <strong>and</strong> fibrillation. Advice from a<br />

consultant cardiac electrophysiologist should be sought<br />

regarding the suitability <strong>of</strong> a patient for this procedure.<br />

Ventricular dysrhythmias<br />

Ventricular ectopic beats: Electrolyte disturbance, smoking,<br />

alcohol abuse <strong>and</strong> excessive caffeine consumption should be<br />

sought <strong>and</strong> corrected if present. The only justification for<br />

treating patients with anti-dysrhythmic drugs in an attempt to<br />

reduce the frequency <strong>of</strong> ventricular ectopic (VE) beats in a<br />

chronic setting is if the ectopic beats cause intolerable palpitations,<br />

or if they precipitate attacks <strong>of</strong> more serious tachydysrhythmia<br />

(e.g. ventricular tachycardia or fibrillation). If<br />

palpitations are so unpleasant as to warrant treatment despite<br />

• Support ABCs; give oxygen; cannulate a vein<br />

• Monitor ECG, BP, SpO 2<br />

• Record 12-lead if possible, if not record rhythm strip<br />

• Identify <strong>and</strong> treat reversible causes<br />

Broad<br />

Is patient stable?<br />

Signs <strong>of</strong> instability include:<br />

1. Reduced conscious level 2. Chest pain<br />

3. Systolic BP �90 mmHg 4. Heart failure<br />

(Rate related symptoms uncommon at less<br />

than 150 beats min �1 )<br />

Regular<br />

Stable<br />

Is QRS narrow (�0.12 sec)?<br />

If ventricular tachycardia<br />

(or uncertain rhythm):<br />

• Amiodarone 300 mg IV<br />

over 20–60 min; then 900 mg<br />

over 24 h<br />

If previously confirmed SVT<br />

with bundle branch block:<br />

• Give adenosine as for regular<br />

narrow complex tachycardia<br />

Regular<br />

Narrow<br />

• Use vagal manoeuvres<br />

• Adenosine 6 mg rapid IV bolus;<br />

if unsuccessful give 12 mg;<br />

if unsuccessful give futher 12 mg.<br />

• Monitor ECG continuously<br />

Normal sinus rhythm<br />

restored?<br />

Yes<br />

Probable re-entry PSVT:<br />

• Record 12-lead ECG in<br />

sinus rhythm<br />

• If recurs, give adenosine<br />

again & consider choice <strong>of</strong><br />

anti-dyshythmic prophylaxis<br />

Is rhythm regular?<br />

Irregular<br />

Irregular narrow complex<br />

tachycardia<br />

Probable atrial fibrillation<br />

Control rate with:<br />

• β-Blocker IV, digoxin IV, or<br />

diltiazem IV<br />

if onset �48 h consider:<br />

• Amiodarone 300 mg IV 20–60<br />

min; then 900 mg over 24 h<br />

Seek expert help<br />

the suspicion that this may shorten rather than prolong life, an<br />

oral class I agent, such as disopyramide, may be considered.<br />

Sotalol with its combination <strong>of</strong> class II <strong>and</strong> III actions is an<br />

alternative, although a clinical trial with the D-isomer (which<br />

is mainly responsible for its class III action) showed that this<br />

worsened survival (the ‘SWORD’ trial).<br />

In an acute setting (most commonly the immediate aftermath<br />

<strong>of</strong> myocardial infarction), treatment to suppress ventricular<br />

ectopic beats may be warranted if these are running<br />

together to form brief recurrent episodes <strong>of</strong> ventricular tachycardia,<br />

or if frequent ectopic beats are present following cardioversion<br />

from ventricular fibrillation. Lidocaine is used in<br />

such situations <strong>and</strong> is given as an intravenous bolus, followed<br />

by an infusion in an attempt to reduce the risk <strong>of</strong> sustained<br />

ventricular tachycardia or ventricular fibrillation.<br />

Ventricular tachycardia: This is covered in Figure 32.3 (management<br />

<strong>of</strong> tachydysrhythmias). In the longer term, consideration<br />

No<br />

Possible atrial flutter<br />

• Control rate (e.g. β-Blocker)<br />

Figure 32.3: Scheme for the management <strong>of</strong> tachydysrhythmias. (Adapted with permission from the European Resuscitation Council<br />

Guidelines, 2005).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!